Editorials:

Standardisation in clinical laboratory medicine: an ethical reflection

Xavier Bossuyt, Céline Louche, and Allan Wiik

Ann Rheum Dis 2008; 67: 1061-1063. doi:10.1136/ard.2007.084228

[Extract] [Full Text] [PDF] [Request Permissions]

Hypothesis:

A biography of the chondrocyte

P A Simkin

Ann Rheum Dis 2008; 67: 1064-1068.
Published Online First: 31 January 2008. doi:10.1136/ard.2007.084574

[Abstract] [Full Text] [PDF] [Request Permissions]

Extended reports:

Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus

M Nikpour, A A Dempsey, M B Urowitz, D D Gladman, and D A Barnes

Ann Rheum Dis 2008; 67: 1069-1075.
Published Online First: 6 December 2007. doi:10.1136/ard.2007.074765

[Abstract] [Full Text] [PDF] [Request Permissions]

CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus

M Mamtani, B Rovin, R Brey, J F Camargo, H Kulkarni, M Herrera, P Correa, S Holliday, J-M Anaya, and S K Ahuja

Ann Rheum Dis 2008; 67: 1076-1083.
Published Online First: 30 October 2007. doi:10.1136/ard.2007.078048

[Abstract] [Full Text] [PDF] [Request Permissions] [web only appendix]

Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial

H K Genant, C G Peterfy, R Westhovens, J-C Becker, R Aranda, G Vratsanos, J Teng, and J M Kremer

Ann Rheum Dis 2008; 67: 1084-1089.
Published Online First: 17 December 2007. doi:10.1136/ard.2007.085084

[Abstract] [Full Text] [PDF] [Request Permissions]

Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study

G A W Bruyn, G Tate, F Caeiro, J Maldonado-Cocco, R Westhovens, H Tannenbaum, M Bell, O Forre, O Bjorneboe, P P Tak, K H Abeywickrama, P Bernhardt, P L C van Riel, and for the RADD study group

Ann Rheum Dis 2008; 67: 1090-1095.
Published Online First: 23 November 2007. doi:10.1136/ard.2007.078808

[Abstract] [Full Text] [PDF] [Request Permissions]

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

M Schiff, M Keiserman, C Codding, S Songcharoen, A Berman, S Nayiager, C Saldate, T Li, R Aranda, J-C Becker, C Lin, P L N Cornet, and M Dougados

Ann Rheum Dis 2008; 67: 1096-1103.
Published Online First: 29 November 2007. doi:10.1136/ard.2007.080002

[Abstract] [Full Text] [PDF] [Request Permissions]

Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial

P L C M van Riel, B Freundlich, D MacPeek, R Pedersen, J R Foehl, A Singh, and on behalf of ADORE study investigators

Ann Rheum Dis 2008; 67: 1104-1110.
Published Online First: 31 July 2007. doi:10.1136/ard.2006.068585

[Abstract] [Full Text] [PDF] [Request Permissions]

Genetic variations in the serotonin 5-HT2_A receptor gene (HTR2A) are associated with rheumatoid arthritis

A Kling, M Seddighzadeh, L Ärlestig, L Alfredsson, S Rantapää-Dahlqvist, and L Padyukov

Ann Rheum Dis 2008; 67: 1111-1115.
Published Online First: 15 November 2007. doi:10.1136/ard.2007.074948

[Abstract] [Full Text] [PDF] [Request Permissions]

Can ultrasonography improve on radiographic assessment in osteoarthritis of the hands? A comparison between radiographic and ultrasonographic detected pathology

H I Keen, R J Wakefield, A J Grainger, E M A Hensor, P Emery, and P G Conaghan

Ann Rheum Dis 2008; 67: 1116-1120.
Published Online First: 23 November 2007. doi:10.1136/ard.2007.079483

[Abstract] [Full Text] [PDF] [Request Permissions]

Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension

F Iannone, M T Riccardi, S Guiducci, R Bizzoca, M Cinelli, M Matucci-Cerinic, and G Lapadula

Ann Rheum Dis 2008; 67: 1121-1126.
Published Online First: 20 November 2007. doi:10.1136/ard.2007.080424

[Abstract] [Full Text] [PDF] [Request Permissions]

Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis

B J Radovits, J Fransen, P L C M van Riel, and R F J M Laan

Ann Rheum Dis 2008; 67: 1127-1131.
Published Online First: 27 October 2007. doi:10.1136/ard.2007.079913

[Abstract] [Full Text] [PDF] [Request Permissions]

B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor antagonists: differential effects between good and poor clinical responders

D T La, C E Collins, H-T Yang, T-S Migone, and W Stohl

Ann Rheum Dis 2008; 67: 1132-1138.
Published Online First: 29 October 2007. doi:10.1136/ard.2007.079954

[Abstract] [Full Text] [PDF] [Request Permissions]

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor expression in the synovium

C A Wijbrandts, M G W Dijkgraaf, M C Kraan, M Vinkenoog, T J Smeets, H Dinant, K Vos, W F Lems, G J Wolbink, D Sijpkens, B A C Dijkmans, and P P Tak

Ann Rheum Dis 2008; 67: 1139-1144.
Published Online First: 29 November 2007. doi:10.1136/ard.2007.080440

[Abstract] [Full Text] [PDF] [Request Permissions]

Focus on adverse events of tumour necrosis factor blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients

V Gerloni, I Pontikaki, M Gattinara, and F Fantini

Ann Rheum Dis 2008; 67: 1145-1152.
Published Online First: 2 November 2007. doi:10.1136/ard.2007.069484

[Abstract] [Full Text] [PDF] [Request Permissions]

Efficient management of rheumatoid arthritis significantly reduces long-term functional disability

E Tanaka, A Mannalithara, E Inoue, M Hara, T Tomatsu, N Kamatani, G Singh, and H Yamanaka

Ann Rheum Dis 2008; 67: 1153-1158.
Published Online First: 30 October 2007. doi:10.1136/ard.2007.072751

[Abstract] [Full Text] [PDF] [Request Permissions]

A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis

S Magni-Manzoni, A Pistorio, E Labò, S Viola, P Garcia-Munitis, S Panigada, C Visconti, A Buoncompagni, A Martini, and A Ravelli

Ann Rheum Dis 2008; 67: 1159-1164.
Published Online First: 26 October 2007. doi:10.1136/ard.2007.078121

[Abstract] [Full Text] [PDF] [Request Permissions]

Innate production of tumour necrosis factor and interleukin 10 is associated with radiological progression of knee osteoarthritis

S Botha-Scheepers, I Watt, E Slagboom, A J M de Craen, I Meulenbelt, F R Rosendaal, F C Breedveld, T W J Huizinga, and M Kloppenburg

Ann Rheum Dis 2008; 67: 1165-1169.
Published Online First: 20 November 2007. doi:10.1136/ard.2007.084657

[Abstract] [Full Text] [PDF] [Request Permissions]

Concise reports:

Predictors of premature gonadal failure in patients with systemic lupus erythematosus. Results from LUMINA, a multiethnic US cohort (LUMINA LVIII)

L A González, G McGwin, Jr, S Durán, G J Pons-Estel, M Apte, L M Vilá, J D Reveille, G S Alarcón, and for the LUMINA Study Group

Ann Rheum Dis 2008; 67: 1170-1173.
Published Online First: 25 February 2008. doi:10.1136/ard.2007.083436

[Abstract] [Full Text] [PDF] [Request Permissions]

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis

E J M Toonen, M J H Coenen, W Kievit, J Fransen, A M Eijsbouts, H Scheffer, T R D J Radstake, M C W Creemers, D-J R A M de Rooij, P L C M van Riel, B Franke, and P Barrera

Ann Rheum Dis 2008; 67: 1174-1177.
Published Online First: 2 April 2008. doi:10.1136/ard.2008.088138

[Abstract] [Full Text] [PDF] [Request Permissions]

Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis?

B Saleem, S Mackie, M Quinn, S Nizam, E Hensor, S Jarrett, P G Conaghan, and P Emery

Ann Rheum Dis 2008; 67: 1178-1180.
Published Online First: 30 January 2008. doi:10.1136/ard.2007.084269

[Abstract] [Full Text] [PDF] [Request Permissions]

Psoriasiform lesions induced by tumour necrosis factor antagonists: a skin-deep medical conundrum

J D Carter, H C Gerard, and A P Hudson

Ann Rheum Dis 2008; 67: 1181-1183.
Published Online First: 25 February 2008. doi:10.1136/ard.2007.082842

[Abstract] [Full Text] [PDF] [Request Permissions]

The synovitis of "non-inflammatory" orthopaedic arthropathies: a quantitative histological and immunohistochemical analysis

F Pessler, L Dai, C Diaz-Torne, C Gomez-Vaquero, M E Paessler, D-H Zheng, E Einhorn, U Range, C Scanzello, and H R Schumacher

Ann Rheum Dis 2008; 67: 1184-1187.
Published Online First: 18 January 2008. doi:10.1136/ard.2008.087775

[Abstract] [Full Text] [PDF] [Request Permissions] [web only appendix]

Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis

C Fiehn, F Kratz, G Sass, U Müller-Ladner, and E Neumann

Ann Rheum Dis 2008; 67: 1188-1191.
Published Online First: 13 April 2008. doi:10.1136/ard.2007.086843

[Abstract] [Full Text] [PDF] [Request Permissions]

Letters:

Multiple sclerosis and systemic sclerosis: efficacy of interferon beta on skin lesions

P B Carrieri, M Petracca, S Montella, M Delfino, C Sepe, and A Gattoni

Ann Rheum Dis 2008; 67: 1192-1193. doi:10.1136/ard.2008.087973

[Extract] [Full Text] [PDF] [Request Permissions]

Pharmacogenetic study of 5,10-methylenetetrahydrofolate reductase C677T and thymidylate synthase 3R/2R gene polymorphisms and methotrexate-related toxicity in Chinese Han patients with inflammatory arthritis

Q-Y Zeng, Y-K Wang, Z-Y Xiao, and S-B Chen

Ann Rheum Dis 2008; 67: 1193-1194. doi:10.1136/ard.2007.085266

[Extract] [Full Text] [PDF] [Request Permissions]

Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritis

K Visser, K N Verpoort, H van Dongen, S M van der Kooij, C F Allaart, R E M Toes, T W J Huizinga, and A H M van der Helm-van Mil

Ann Rheum Dis 2008; 67: 1194-1195. doi:10.1136/ard.2008.088070

[Extract] [Full Text] [PDF] [Request Permissions]

Is there any role for tumour necrosis factor related apoptosis inducing ligand–osteoprotegerin (TRAIL–OPG) interaction in rheumatoid arthritis?

G Castellino, F Corallini, F Trotta, and P Secchiero

Ann Rheum Dis 2008; 67: 1196-1197. doi:10.1136/ard.2007.081067

[Extract] [Full Text] [PDF] [Request Permissions]

Investigating the role of CD24 gene polymorphisms in rheumatoid arthritis

E Sánchez, B Fernández-Gutierrez, M Á González-Gay, A Balsa, A García, L Rodríguez, D Pascual-Salcedo, M F González-Escribano, and J Martin

Ann Rheum Dis 2008; 67: 1197-1198. doi:10.1136/ard.2007.084475

[Extract] [Full Text] [PDF] [Request Permissions]

Ultrasound-guided intra-articular injections in the wrist in patients with rheumatoid arthritis: a double-blind, randomised controlled study

K R Luz, R N V Furtado, C C G Nunes, A Rosenfeld, A R C Fernandes, and J Natour

Ann Rheum Dis 2008; 67: 1198-1200. doi:10.1136/ard.2007.084616

[Extract] [Full Text] [PDF] [Request Permissions]

Correction

Ann Rheum Dis 2008; 67: 1200. doi:10.1136/ard.2007.075523.corr1

[Extract] [Full Text] [PDF] [Request Permissions]